Optical rotations were determined using a JASCO DIP-370 digital polarimeter. CD spectra were measured on a JASCO J-725 spectropolarimeter. UV spectra were obtained on a Beckman DU-530 spectrophotometer, and IR spectra were obtained using a JASCO FT/IR-4200 spectrophotometer.
recorded on a JEOL ECA-500 spectrometer, and the chemical shifts were expressed on the  (ppm) scale with TMS as an internal standard. EI-MS and HR-EI-MS were recorded on a JEOL JMS-SX 102A spectrometer. Column chromatography (CC) was carried out on Merck silica gel (230400 mesh). Spots on TLC plates (Merck silica gel 60 F 254 ) were detected with a UV lamp or by I 2 vapor.
Extraction and isolation
The finely powdered roots (2.5 kg) were macerated with acetone (2  14 L) at room temperature and the solvent was removed to give a residue, which was extracted successively into n-hexane, CHCl 3 , and EtOAc. The CHCl 3 extract (183.1 g) was applied to silica gel (3500 g, 10  90 cm) CC eluting with CHCl 3 Me 2 CO (20:1, 20:3, 3:1, 1:1, 10 L each) and Me 2 CO (10 L) to give 7 fractions (A1A7). Fr. A3 (33.0 g) was subjected to silica gel (1200 g, 10  30 cm) CC eluting with CHCl 3 Me 2 CO (40:1, 20:3, 1:1, 2 L each) to give 8 fractions (B1B8). Fr. B3 (5.08 g) was purified by silica gel (200 g, 4.5  24 cm) CC eluting with nhexaneMe 2 CO (5:1, 1:1, 125 mL each) to give 8 fractions (C1C8). Fr. C4 (303 mg) was purified by silica gel (10 g, 1.0  27 cm) CC eluting with CHCl 3 Me 2 CO (40:1, 20:3) to give eryvariestyrene (4) (44.4 mg). Fr. C7 (235 mg) was purified by repeated silica gel CC using benzeneEtOAc (40:1) to give bidwillol A (7) (7.1 mg). Frs. B4 and B5 (14.8 g) were subjected to silica gel (450 g, 5.5  38 cm) CC eluting with n-hexaneMe 2 CO (5:1, 3:1, 600 mL) to give 6 fractions (D1D6). Fr. D4 (10 g) was subjected to silica gel CC using CHCl 3 Me 2 CO (40:1, 20:3) and subsequent silica gel CC using benzeneEtOAc (20:1, 10:1, 3:1) to give a crude mixture (136 mg), which was separated by preparative TLC using nhexaneMe 2 CO (3:1) to give phaseollinisoflavan (8) (8.6 mg, R f = 0.34) and erythbidin A (9) (25.9 mg, R f = 0.28). Fr. D5 (1.22 g) was purified twice by preparative TLC using benzeneEtOAc (3:1) to give eryvarin L (11) (16.3 mg, R f = 0.34). Fr. A4 (40.0 g) was applied to silica gel (1200 g, 10  31 cm) CC eluting with CHCl 3 Me 2 CO (20:1, 10:1, 1:1, 500 mL each) to give 25 fractions (F1F25). Frs. F7 and F8 (7.93 g) were separated by silica gel (240 g, 4.5  29 cm) CC eluting with n-hexaneMe 2 CO (3:1, 2:1, 200 mL each) to give 8 fractions (G1G8). Fr. G5 (192 mg) was purified by repeated silica gel CC using benzeneEtOAc (10:1) to give phaseollidin isoflavan (10) (27 mg). Fr. G7 (363 mg) was purified by silica gel CC using n-hexaneMe 2 CO (3:1, 1:1) to give eryvarin H (6) (56.4 mg).
Frs. F12 and F13 (5.13 g) were subjected to silica gel (140 g, 4.5  17 cm) CC eluting with benzeneEtOAc (20:1, 10:1, 1:1, 80 mL each) to give 10 fractions (H1H10). Fr. H4 (4 g) was purified by silica gel CC eluting with CHCl 3 Me 2 CO (40:1, 20:3) and subsequent silica gel CC using benzeneEtOAc (20:1, 10:1) to give glabrocoumarone A (12) (15.5 mg). Fr. H8 (393 mg) was separated by silica gel CC using CHCl 3 Me 2 CO (40:1) to give 6-formyl-2,2-dimethyl-2H-chromene (3) (6.4 mg) and erybacin A (1) (10.1 mg). Frs. F14 and F15 (2.49 g) were applied to silica gel (100 g, 3  35 cm) CC using n-hexaneMe 2 CO (5:1, 3:1, 2:1, 300 mL each) to give 9 fractions (I1I9). Fr. I3 (345 mg) was separated by silica gel CC using CHCl 3 Me 2 CO (40:1, 20:3) and subsequently benzeneEtOAc (3:1) to give erybacin B (2) (13.8 mg) and (±)-glyasperin F (5) (60.8 mg). 
6-Formyl-2,2-dimethyl-2H-chromene

Antibacterial assay
Bacterial cell suspensions (10 7 colony-forming units/mL) of 13 MRSA strains were prepared using Mueller Hinton broth (Difco). MIC was determined by the broth dilution technique.
Fresh MuellerHinton broth (890 L) and twofold serial dilutions of the compounds in DMSO (10 L) were added to the wells of a multi-well plate, followed by inoculation of bacterial cell suspensions (100 L). The final concentration range of the tested compounds was 1.5650 g/mL. The plates were aerobically incubated at 37 C for 24 h. MIC was defined as the lowest concentration at which no visible bacterial growth was observed.
Aliquots (20 L) were removed from the wells that inhibited visible bacterial growth and streaked onto MullerHinton agar plates. The agar plates were incubated in the same conditions. MBC was defined as the lowest concentration at which colonies failed to grow. 
